surmount trials tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Diabetes & Weight Loss Drug

Convenience: With online consultations and chat support, you can get care when you need it without long wait times or office visits

Its recommended to increase the dose gradually (every four weeks) if additional blood sugar management is needed

Dose Conversion Tirzepatide Dose and Units Calculator Convert a prescribed dose into medication volume and syringe units using the selected concentration

In fact, the differences between them are significant enough that choosing one over the other could meaningfully affect results, side effects and suitability

However, it is better absorbed, and the best way to receive it is intravenously